Follow
April Weissmiller
April Weissmiller
Verified email at mtsu.edu
Title
Cited by
Cited by
Year
Current advances in using neurotrophic factors to treat neurodegenerative disorders
AM Weissmiller, C Wu
Translational neurodegeneration 1 (1), 1-9, 2012
2252012
Amyloid precursor protein–mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration
W Xu, AM Weissmiller, JA White, F Fang, X Wang, Y Wu, ML Pearn, ...
The Journal of clinical investigation 126 (5), 1815-1833, 2016
1862016
Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance
LR Thomas, CM Adams, J Wang, AM Weissmiller, J Creighton, SL Lorey, ...
Proceedings of the National Academy of Sciences 116 (50), 25260-25268, 2019
1052019
Displacement of WDR5 from chromatin by a WIN site inhibitor with picomolar affinity
ER Aho, J Wang, RD Gogliotti, GC Howard, J Phan, P Acharya, ...
Cell reports 26 (11), 2916-2928. e13, 2019
982019
Inhibition of MYC by the SMARCB1 tumor suppressor
AM Weissmiller, J Wang, SL Lorey, GC Howard, E Martinez, Q Liu, ...
Nature communications 10 (1), 1-12, 2019
842019
The MYC–WDR5 nexus and cancer
LR Thomas, AM Foshage, AM Weissmiller, WP Tansey
Cancer research 75 (19), 4012-4015, 2015
732015
MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1
TM Popay, J Wang, CM Adams, GC Howard, SG Codreanu, SD Sherrod, ...
Elife 10, e60191, 2021
712021
Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects
EM Rodrigues, AM Weissmiller, LSB Goldstein
Human molecular genetics 21 (21), 4587-4601, 2012
682012
WDR5 is a conserved regulator of protein synthesis gene expression
AF Bryan, J Wang, GC Howard, AD Guarnaccia, CM Woodley, ER Aho, ...
Nucleic acids research 48 (6), 2924-2941, 2020
572020
Impact of WIN site inhibitor on the WDR5 interactome
AD Guarnaccia, KL Rose, J Wang, B Zhao, TM Popay, CE Wang, ...
Cell reports 34 (3), 108636, 2021
512021
Interaction of MYC with host cell factor-1 is mediated by the evolutionarily conserved Myc box IV motif
LR Thomas, AM Foshage, AM Weissmiller, TM Popay, BC Grieb, ...
Oncogene 35 (27), 3613-3618, 2016
502016
Real-time imaging of axonal transport of quantum dot-labeled BDNF in primary neurons
X Zhao, Y Zhou, AM Weissmiller, ML Pearn, WC Mobley, C Wu
JoVE (Journal of Visualized Experiments), e51899, 2014
442014
A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: Evidence for a role for APP
AM Weissmiller, O Natera-Naranjo, SM Reyna, ML Pearn, X Zhao, ...
PloS one 10 (2), e0118379, 2015
392015
Targeting WDR5: A WINning anti-cancer strategy?
ER Aho, AM Weissmiller, SW Fesik, WP Tansey
Epigenetics insights 12, 2516865719865282, 2019
342019
Functional impact of corticotropin-releasing factor exposure on tau phosphorylation and axon transport
MH Le, AM Weissmiller, L Monte, PH Lin, TC Hexom, O Natera, C Wu, ...
PloS one 11 (1), e0147250, 2016
262016
Emerging Themes in Mechanisms of Tumorigenesis by SWI/SNF Subunit Mutation
CA Jones, WP Tansey, AM Weissmiller
Epigenetics Insights 15, 25168657221115656, 2022
222022
WIN site inhibition disrupts a subset of WDR5 function
AJ Siladi, J Wang, AC Florian, LR Thomas, JH Creighton, BK Matlock, ...
Scientific Reports 12 (1), 1-11, 2022
222022
Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler
CM Woodley, AS Romer, J Wang, AD Guarnaccia, DL Elion, JN Maxwell, ...
Oncogene 40 (20), 3593-3609, 2021
172021
Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome
RL Nosheny, PV Belichenko, BL Busse, AM Weissmiller, V Dang, D Das, ...
Neurobiology of disease 77, 173-190, 2015
172015
Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells
AC Florian, CM Woodley, J Wang, BC Grieb, MJ Slota, K Guerrazzi, ...
NAR Cancer 4 (1), zcac007, 2022
132022
The system can't perform the operation now. Try again later.
Articles 1–20